Where does Cyclone Biosciences, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cyclone Biosciences, LLC ranks #14,552 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cyclone Biosciences, LLC hold?

Cyclone Biosciences, LLC holds 20 US utility patents granted between 2017 and 2025, spanning 9 technology areas.

What is Cyclone Biosciences, LLC's Innovation Score?

Cyclone Biosciences, LLC has an Innovation Score of 49.4 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cyclone Biosciences, LLC focus on?

Cyclone Biosciences, LLC's top technology area is G02B (Optical Elements, Systems OR Apparatus) with 14 patents, ranking #859 of 4,891 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Cyclone Biosciences, LLC's patent grant rate increasing or decreasing?

Cyclone Biosciences, LLC's recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cyclone Biosciences, LLC's patents?

Cyclone Biosciences, LLC's patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cyclone Biosciences, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cyclone Biosciences, LLC

USPTO PatentsView assignee record - 20 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cyclone ranks #14,552 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 9 technology areas.

#14,552
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.4/100): 13.8
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14552 · US Corporation #14,552 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,552/49,997
PHOTO-FINISH Cablofil
CPC-NARROW G02B · 9 areas
INNOV-PAR 49.4/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cablofil, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cyclone’s 49.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (21%) Velocity 20.0 pts (40%) Breadth 10.6 pts (21%) Claim depth 8.3 pts (17%)

Qualcomm Incorporated · highest

85
Cyclone Biosciences · this assignee

49
3D Lighting… · lowest

7

What this shows Cyclone's Innovation Score is 49.4/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cyclone?

Each dot is one of Cyclone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cyclone’s own 13.8 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cyclone vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cyclone's grants concentrate

Cyclone Biosciences, LLC is a focused PatentsView assignee: 9 CPC subclasses with 70% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2024 (8 grants) versus a trough of 1 in 2017. By volume, Cyclone sits between Crius Technology Group, LLC and Campbell Soup Company.

Cyclone's three-year grant acceleration

Cyclone Biosciences, LLC shows 11 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Crius Technology…

20
CRS Holdings

20
Crystal Bioscience

20
CVF Motorsports

20
Cablofil

20
Calumino Pty

20
Camcal Enterprises

20
Campbell Soup

20
Cyclone Bioscienc… ◀

20

What this shows Cyclone holds 20 patents at rank #14,528, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cyclone

By rank, the assignees closest to #14,528 in granted patent volume.

Leaders in G02B (Optical Elements)

Other assignees with the most granted patents in Cyclone's primary technology class.

Cyclone's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Cyclone Biosciences, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	5.0%
2018	1	5.0%
2020	1	5.0%
2021	2	10.0%
2022	1	5.0%
2023	2	10.0%
2024	8	40.0%
2025partial year	4	20.0%

Which technologies does Cyclone Biosciences, LLC patent most?

G02B - Optical Elements, Systems OR Apparatus 14

A61B - DIAGNOSIS; SURGERY; Identification 11

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

H04N - Pictorial Communication, e.g. Television 3

G06N - Computing Arrangements Based ON Specific Computational Models 3

B24B - Machines, Devices, OR Processes FOR Grinding OR Polishing ; Dressing OR Conditioning OF Abrading SURFACES; Feeding OF Grinding, Polishing, OR Lapping Agents 2

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cyclone Biosciences, LLC's patent record in context - here's where to go next.

Cyclone Biosciences, LLC's lead technology class is G02B (Optical Elements, Systems OR Apparatus), 70% of its portfolio - see every assignee active in that class. Explore G02B
Ranked #14,552 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cyclone Biosciences, LLC against Crius Technology Group, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.